SUDOSCAN
SUDOSCAN: An innovative device for the early detection and tracking of autonomic and microfibrous neuropathies.
Quantitative results are available within 3 minutes. Completely non-invasive. No fasting or patient preparation is required.
What is SUDOSCAN?
SUDOSCAN is a unique and innovative device. It’s a simple and non-invasive technology, able to detect and follow small fibers neuropathy that are usually not detected by the traditional tools.
How to use SUDOSCAN?
The device consists of a computer and 4 electrodes on which patients place their hands and bare feet. In less than 3 minutes, SUDOSCAN offers stimulation of the sweat glands that assess small nerve fibers (C fibers). This early detection improves disease management and helps to prevent severe complications associated with some diseases.
Overview - SUDOSCAN Principles
SUDOSCAN measures the ability of the sweat glands to release chloride ions in response to an electrical stimulus on the palms of the hands and soles of the feet, areas with the highest sweat gland density.
The utility of SUDOSCAN has been demonstrated in:
-
Neurology: for the assessment and follow-up of conditions such as neuropathic pain management, idiopathic neuropathies, Gougerot Sjögren, amyloidosis, Fabry disease etc.
-
Diabetology: for the early detection of peripheral neuropathy and sweat gland dysfunction, useful for the prevention of diabetic foot complications.
-
Oncology: for a quantitative assessment of chemotherapy-induced Neuropathy, allowing a better and informed decision.
-
Follow-up: for patient management, longitudinal treatment follow-up and lifestyle interventions
A trusted technology
CE Certified
Cleared for user by US FDA
SUDOSCAN has similar results to reference tests such as: skin biopsy, QSART, or clinical scores like NIS-LL. The technology is backed by over 250 publications in international scientific journals.
The device is manufactured in France and the test is very sensible and highly reproducible.
SUDOSCAN is CE certified, cleared for use by the US FDA, and is registered and distributed in 34 countries with more than 5000 devices sold.
Applications
Diabetes
Diabetes complications
– SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
– SUDOSCAN also helps for a better management of diabetes complications such as diabetic foot and cardiac autonomic neuropathy and follow up disease progression.
Neurology
Diseases with neurological complications
SUDOSCAN have been applied to several diseases with neurological complications, such as Hereditary amyloidosis, Idiopathic Neuropathies, Covid-19, Fabry disease, Parkinson’s disease, Autoimmune small fiber neuropathy, Fibromyalgia, Sjörgen’s syndrome, Pure autonomic failure, Hepatitis C.
Oncology
Chemotherapy induced peripheral neuropathy
SUDOSCAN can easily be performed in the Oncology department, before and after treatment for an optimal follow-up of patients of the Chemotherapy lnduced Polyneuropathy (CIPN). SUDOSCAN results are correlated to the Total Neuropathy Score (TNSc) clinical evaluation: reduced for TNSc > 6 population.
Follow-up
Monitoring of patient outcomes
Another key application of SUDOSCAN is patient management, longitudinal treatment follow-up and lifestyle impact. SUDOSCAN was used to evaluate the effect of physical activity on cardiovascular risk and metabolic diseases.
SUDOSCAN Benefits
Fast
-
No patient preparation
-
Results in 3 minutes
-
Easy-to-read critical data points to help physicians reach a diagnosis
Secure
-
Non-invasive
-
No fasting
-
Easy to operate
-
CE and FDA approvals
Accurate
-
Reproducible quantitative results
-
Independent from environmental conditions
-
Backed by evidence-based research
-
270 peer-reviewed journals publications